NCT04619004 2026-01-23HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung CancerDaiichi SankyoPhase 2 Active not recruiting277 enrolled 16 charts
NCT03732274 2025-04-10Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLCMedPacto, Inc.Phase 1/2 Completed60 enrolled